Our President & CEO Eric Halioua will make a company presentation at the Belgium-Korea Pharma-Bio Partnering on the 13th November 2019 in Brussels. This seminar organized by Korea Trade-Investment...

Thursday, our President & CEO Eric Halioua, will make a company presentation and be chairman of a session on “Therapeutic Vaccines and Oncolytics” at the World Immunotherapy Congress taking place in...

Our CEO & President Eric Halioua will be presenting PDC*line Pharma updates at the Alliance for Regenerative Medicine 's Cell & Gene Meeting on the Mesa 2019, October 2-4, Carlsbad, CA (USA). 

Organi...

Eric Halioua, President & CEO of PDC*line Pharma will be a panelist in a round table on Oncology Advanced Therapeutics & Diagnostics at the 19th Biotech in Europe Forum. A Sachs Associates event...

Liège, Belgium, and Grenoble, France, September 9, 2019 – PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, announces...

Our President & CEO Eric Halioua will present the unique mechanism of action of our proprietary Plasmacytoid Dendritic Cell line (PDC*line) at the "Science for Health 2019"! Come join the Cell Therapy...

Have a look to the great video made by MATWIN for its 10 years anniversary serving innovation in oncology ! The video includes a contribution of PDC*line Pharma with an interview of our CEO Eric...

PDC*line Pharma is - for the first time – an active partner of the Forum BIOTechno Auvergne-Rhône-Alpes 2019. The event will take place June, 11th at the Centre de Congrès du World Trade Center...

Please read our recent publication in the June 2019 edition of Nature Biopharma Dealmakers! The article highlights the key competitive advantages of our technology PDC*vac: a highly potent, versatile...

The PDC*line Pharma management team will be present in full force to 2019 BIO International Convention in Philadelphia from June 3rd to June 6th! ? Contact us through the One-on-One Partnering™ or...